| 2009 | In vitro activities of panduratin A against clinical Staphylococcus strains
| ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| 2021 | In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea
| PHARMACEUTICALS |
| 2020 | In Vitro Activity of a Novel Siderophore-Cephalosporin, GT-1 and Serine-Type β-Lactamase Inhibitor, GT-055, against Escherichia coli, Klebsiella pneumoniae and Acinetobacter spp. Panel Strains
| ANTIBIOTICS-BASEL |
| 2002 | In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2015 | In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study
| ANNALS OF LABORATORY MEDICINE |
| 2017 | In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE |
| 2011 | In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms | MEDICAL MYCOLOGY |
| 2010 | In vitro antibacterial activity of panduratin A against enterococci clinical isolates.
| BIOLOGICAL & PHARMACEUTICAL BULLETIN |
| 2006 | In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb
| JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| 2016 | In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE |
| 2008 | In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells | TRANSFUSION |
| 2023 | In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources
| STEM CELL RESEARCH & THERAPY |
| 2013 | In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
| ANNALS OF LABORATORY MEDICINE |
| 2016 | In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
| ANNALS OF LABORATORY MEDICINE |
| 2016 | In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
| ANNALS OF LABORATORY MEDICINE |
| 2016 | In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357
| APPLIED AND ENVIRONMENTAL MICROBIOLOGY |
| 2019 | In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia
| SCIENTIFIC REPORTS |
| 2014 | In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE |
| 2011 | In vivo hepatic differentiation potential of human cord blood-derived mesenchymal stem cells | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2022 | In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model
| THERANOSTICS |
